CytomX Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
151 Oyster Point Blvd., Suite 400, South San Francisco, California

Insiders trading volume in the past year

CytomX Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sean A. McCarthy CEO, Director $1.5M -$79.9K -5.04% Mar 26, 2024
Marcia Belvin SVP, Chief Scientific Officer $455K -$37.7K -7.64% Mar 19, 2024
Jeffrey B. Landau Chief Business Officer $349K -$24.7K -6.6% Mar 19, 2024
Lloyd Rowland General Counsel $349K -$23.8K -6.37% Mar 19, 2024
Christopher Ogden SVP, Finance and Accounting $282K -$8.94K -3.07% Mar 19, 2024
Yu-Waye Chu Chief Medical Officer $140K Jan 18, 2024
Alison L. Hannah Chief Medical Officer $85.5K Jul 19, 2022
Amy C. Peterson EVP, Chief Development Officer $80.7K Mar 16, 2023
Carlos Campoy Chief Financial Officer $52.8K Mar 16, 2023
Matthew P. Young Director May 15, 2024
Alan Ashworth Director May 15, 2024
R. James Meyers Director May 15, 2024
Halley E. Gilbert Director May 15, 2024
Zhen Su Director May 15, 2024
Mani Mohindru Director May 15, 2024
Elaine V. Jones Director May 15, 2024
Frederick W. Gluck Director Jun 15, 2022
John A. Scarlett Director Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for CytomX Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership